Get started
Author

Saman Hewamana

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
2008 · Chris Pepper, Thet Thet Lin, et al. · Blood · 253
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis
2010 · Thet Thet Lin, Boitelo T. Letsolo, et al. · Blood · 184
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
2008 · Saman Hewamana, Suhair Alghazal, et al. · Blood · 161
PDF
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
2011 · Claire E. Dearden, Amit Khot, et al. · Blood · 101
PDF
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription
2010 · Andrea G.S. Buggins, Chris Pepper, et al. · Cancer Research · 93
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
2010 · Aneela Majid, Thet Thet Lin, et al. · Leukemia Research · 67
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
2009 · Saman Hewamana, Thet Thet Lin, et al. · Journal of Clinical Oncology · 57
PDF
Defining the prognosis of early stage chronic lymphocytic leukaemia patients
2011 · Chris Pepper, Aneela Majid, et al. · British Journal of Haematology · 55
PDF
Targeting transcription factors for therapeutic benefit
2008 · Paul Brennan, Rossen Donev, et al. · Molecular BioSystems · 45
The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine
2008 · Saman Hewamana, Thet Thet Lin, et al. · Clinical Cancer Research · 43
PDF
NF-κB as a Prognostic Marker and Therapeutic Target in Chronic Lymphocytic Leukemia
2009 · Chris Pepper, Saman Hewamana, et al. · Future Oncology · 33
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2
2011 · C. Pepper, J. G. Mahdi, et al. · Cell Proliferation · 29
Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia
2009 · Saman Hewamana, Chris Pepper, et al. · Clinical and Experimental Nephrology · 23
Nuclear factor‐κB as a potential therapeutic target for the novel cytotoxic agent LC‐1 in acute myeloid leukaemia
2008 · Christopher Jenkins, Saman Hewamana, et al. · British Journal of Haematology · 21
PDF
Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy
2009 · Saman Hewamana, Belinda Austen, et al. · European Journal Of Haematology · 20
Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia
2010 · Christopher Jenkins, Saman Hewamana, et al. · Leukemia Research · 18
Highly purified CD38+ sub‐populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38− sub‐populations derived from the same chronic lymphocytic leukaemia patient
2008 · Thet Thet Lin, Saman Hewamana, et al. · British Journal of Haematology · 15
Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka
2021 · Saman Hewamana, Lakmali Kandabadage, et al. · EClinicalMedicine · 14
PDF
Quantitative nuclear proteomics reveals new phenotypes altered in lymphoblastoid cells
2009 · Paul Brennan, Angharad M. Shore, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 12
Techniques for effective bedside teaching
2007 · Christopher Jenkins, Charlotte Page, et al. · British Journal of Hospital Medicine · 11
Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38
2010 · L. Pearce, L. Morgan, et al. · Haematologica · 10
PDF
Treatment options for high-risk chronic lymphocytic leukaemia
2011 · Saman Hewamana, Claire Dearden · Therapeutic Advances in Hematology · 9
PDF
Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka
2021 · Saman Hewamana, Thurairajah Skandarajah, et al. · PLoS ONE · 7
PDF
Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting
2024 · Saman Hewamana, Thurairajah Skandarajah, et al. · JCO Global Oncology · 6
The NF-κB Inhibitor LC-1 Has Single Agent Activity in Multiple Myeloma Cells and Synergizes with Bortezomib
2010 · Elisabeth J. Walsby, Guy Pratt, et al. · Molecular Cancer Therapeutics · 5
Works count: 49
Citation count: 1,313
H-index: 16
I10-index: 21
Year
Topic
Type